Form 4: Takeda Pharmaceutical Co President Sells Shares
Insider Transaction (Form 4)
Andrew Stewart Plump, President, R&D and a Director of Takeda Pharmaceutical Co Ltd, sold 116,191 shares of common stock on September 2, 2026 for $18.49 per share.
Summary
- Open-market sale: disposed of 116,191 American Depositary Shares at $18.49 ($2,148,372) on September 2, 2026; holds 145,465 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $2,148,372 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Andrew Stewart Plump — Director, Officer (President, R&D)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-02 | Open-market sale | American Depositary Shares | 116,191 | $18 | $2.1M | 145,465 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-02 | Open-market sale (116,191 shares) |
Keywords
insider transaction, Form 4, TAK, TAKEDA PHARMACEUTICAL CO LTD, bearish, Andrew Stewart Plump
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.